Speaking of SurgOnc
56 episodes - English - Latest episode: 20 days ago - ★★★★★ - 6 ratings"Speaking of SurgOnc" is a podcast series brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology(SSO). Dr. Frederick L. (Rick) Greene, ASO Deputy Editor, will explore and expand upon ideas and concepts described in articles published in the Annals of Surgical Oncology. Dr. Greene will interview authors and leading experts about topics of current importance in surgical oncology.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6
April 09, 2024 05:00 - 16 minutes - 15.5 MBRick Greene, MD, discusses with Anthony Villano, MD, a review the American College of Surgeons Commission on Cancer Standard 5.6, which pertains to curative intent colon resections performed for cancer. Dr. Villano is author of "Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6." Dr. Villano is the Assistant Professor, Surgical Oncology, in the Department of Surgical Oncology, at Fox Chase Cancer Center in Phila...
Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer
March 12, 2024 05:00 - 20 minutes - 19.1 MBRick Greene, MD, discusses with Jean-Nicolas Vauthey, MD, a comparison of different surgical approaches to synchronous liver metastases from rectal cancer and their analysis of both clinicopathological and biological tumor factors associated with completion of the reverse approach. Professor Vauthey is the senior author of, “Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer.” Dr. Vauthey is Professor of Surgery and Chief of...
Hospital Designations and Their Impact on Guideline-Concordant Care and Survival in Pancreatic Cancer. Do They Matter?
February 13, 2024 06:00 - 17 minutes - 24.3 MBRick Greene, MD, discusses with Patricio M. Polanco, MD, an analysis of three hospital designations, as well as volume status, and their effect on the delivery of care and survival outcomes using a cancer registry database of the second largest state in the USA. Dr. Polanco is co-corresponding author of, “Hospital Designations and Their Impact on Guideline-Concordant Care and Survival in Pancreatic Cancer. Do They Matter?.”
Benchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multicenter Study
January 09, 2024 06:00 - 17 minutes - 23.7 MBRick Greene, MD, discusses with Eduardo A. Vega, MD, definitions reported on of benchmark values for gallbladder cancer surgery across an international population as well as geographic differences in gallbladder cancer surgery across multiple continents. Dr. Vega is the senior author of, “Benchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multicenter Study.” Dr. Vega is Assistant Professor of Surgery at Boston University School of Medicine and Hepato-Bili...
CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic Cancer
December 12, 2023 06:00 - 15 minutes - 21.3 MBRick Greene, MD, discusses with Susan Tsai, MD, MHS, the results of an analysis examining the efficacy of second-line gemcitabine/nab-paclitaxel (GnP) after first-line FOLFIRINOX in the neoadjuvant setting among patients with operable pancreatic cancer who were treated with a total neoadjuvant approach. Dr. Tsai is the senior author of, “CA19-9 Response to First-line Neoadjuvant FOLFIRINOX and Second-line Gemcitabine/nab- Paclitaxel in Patients with Operable Pancreatic Cancer.” Dr. Tsai is...
Neuroendocrine Tumor Liver Metastases: Long-Term Follow-up Evaluation of More Than 500 Patients
November 14, 2023 06:00 - 16 minutes - 22.2 MBRick Greene, MD, discusses with Sean Cleary, MD, cytoreductive hepatectomy for neuroendocrine tumor liver metastases; specifically, perioperative outcomes and operative trends, rates and duration of symptomatic relief, and long-term survival and predictors of prognosis. Dr. Cleary is the senior author of, “Neuroendocrine Tumor Liver Metastases: Long-Term Follow-up Evaluation of More Than 500 Patients.” Dr. Cleary is the Bernard and Ryna Langer Chair of the Division of General Surgery in th...
Endocrine Therapy for Surgeons: Practical Pearls for Managing Menopausal, Bone Loss and Sexual Adverse Effects
October 10, 2023 05:00 - 17 minutes - 23.5 MBRick Greene, MD, discusses with Anna Weiss, MD, the evidence-based treatments available for the adverse effects of endocrine therapy that can be experienced by breast cancer patients, including clear treatment algorithms for genitourinary syndrome of menopause (GSM), which can be overlooked by providers. Dr. Weiss is the senior author of, “Endocrine Therapy for Surgeons: Practical Pearls for Managing Menopausal, Bone Loss and Sexual Adverse Effects.” Dr. Weiss is Associate Professor of Sur...
Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I–III Breast Cancer
September 12, 2023 05:00 - 15 minutes - 20.6 MBRick Greene, MD, and Tari King, MD, FSSO, discuss findings generated from central path review of a large series of patients treated with neoadjuvant chemotherapy and surgery regarding the pattern of residual tumor in the breast and its related prognostic significance. Dr. King is the senior author of, “Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I–III Breast Cancer.” Dr. Tari A. King is the Anne E. Dyson Professor of...
Long-Term Survival in Patients Treated with Cytoreduction and Heated Intraperitoneal Chemotherapy for Peritoneal Mesothelioma at a Single High-Volume Center
August 08, 2023 05:00 - 14 minutes - 19.9 MBRick Greene, MD discusses with Edward A. Levine, MD, long-term survival in patients with malignant peritoneal mesothelioma undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Dr. Levine is the senior author of, “Long-Term Survival in Patients Treated with Cytoreduction and Heated Intraperitoneal Chemotherapy for Peritoneal Mesothelioma at a Single High-Volume Center.” Dr. Levine is Professor, Surgical Sciences - Oncology, Chief of Surgical Oncology at Atrium Wa...
Exploring the Potential of Artificial Intelligence in Surgery: Insights from a Conversation with ChatGPT
July 11, 2023 05:00 - 16 minutes - 23 MBRick Greene, MD, discusses with Jesse Selber MD, MPH, MHCM, FACS, the use of ChatGPT and explores questions regarding the potential of artificial intelligence (AI) in surgery and its opportunities, challenges, and possible role in surgery. Dr. Selber is the senior author of the article entitled "Exploring the Potential of Artificial Intelligence in Surgery: Insights from a Conversation with ChatGPT.” Dr. Selber is Surgical Service Line Chief and Professor of Plastic Surgery at Corewell Hea...
A Model to Predict Treatment Failure in Patients Undergoing Upfront Surgery for Resectable Colorectal Liver Metastases
June 13, 2023 05:00 - 12 minutes - 16.5 MBRick Greene, MD, discusses with Giammauro Berardi, MD, PhD, FEBS, the outcomes of a large cohort of patients undergoing upfront surgery for resectable colorectal liver metastases (CRLM) to analyze the predictability and probability of early treatment failure using clinicopathological characteristics. Dr. Berardi is author of, “A Model to Predict Treatment Failure in Patients Undergoing Upfront Surgery for Resectable Colorectal Liver Metastases.” Dr. Berardi is attending at the Department o...
Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients
May 09, 2023 06:00 - 17 minutes - 24.1 MBRick Greene, MD, discusses with Julie Culver, MS, LCGC, CCRP, the implementation of genetic testing for all patients with breast cancer and how this can be incorporated into oncology care. Ms. Culver is author of “Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients.” Julie Culver is the Director of Genetic Counseling at the USC Norris Cancer Hospital and is a Clinical Instructor of Medicine at the USC Keck School of Medicine, Los Angeles, CA. http://doi...
Is Routine Omentectomy a Necessary Component of Cytoreductive Surgery and HIPEC?
April 11, 2023 06:00 - 13 minutes - 18 MBRick Greene, MD, discusses with Joel Baumgartner, MD, the rate of occult omental metastases in patients undergoing cytoreductive surgery-HIPEC for peritoneal surface malignancy. Dr. Baumgartner is author of, “Is Routine Omentectomy a Necessary Component of Cytoreductive Surgery and HIPEC?” Dr. Baumgartner is Associate Professor in the Department of Surgery, UC San Diego School of Medicine, San Diego, CA. http://doi.org/10.1245/S10434-022-12714-7
Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292)
March 14, 2023 17:00 - 17 minutes - 23.9 MBRick Greene, MD, discusses with Margaret Kemeny, MD, the results of a phase III randomized trial that evaluated the effect of perioperative fluorouracil on overall survival in colon cancer. Dr. Kemeny is author of, "Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292)." Dr. Kemeny is Director of New York's Cancer Center of Excellence at Queens Cancer Center of NYC Health...
Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers
February 14, 2023 06:00 - 13 minutes - 19.1 MBRick Greene, MD, discusses with Meghan R. Flanagan, MD, MPH, the results of a retrospective population-based study about genetic testing among patients with breast, ovarian, pancreatic and prostate cancers. Dr. Flanagan is author of, “Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers.” Dr. Flanagan is Assistant Professor of Surgery at the University of Washington School of Medicine, Seattle, WA. http://doi.org/10.1245/S10434-022-12755-Y
Patient-Reported Outcome Measures in Patients with Clinical T4 Breast Cancer Treated with Mastectomy with and without Reconstruction
January 10, 2023 06:00 - 10 minutes - 14.8 MBRick Greene, MD, and Audree Tadros, MD, MPH, FACS, discuss the BREAST-Q, a validated patient-reported outcome measure for satisfaction and quality of life after breast surgery, to determine whether patient satisfaction and quality of life differs among T4 breast cancer patients based on their decision to pursue reconstruction and the timing of reconstruction. Dr. Tadros is author of “Patient-Reported Outcome Measures in Patients with Clinical T4 Breast Cancer Treated with Mastectomy with and...
Disparities in Utilization and Outcomes of Minimally Invasive Techniques for Gastric Cancer Surgery in the United States
December 20, 2022 06:00 - 12 minutes - 16.7 MBRick Greene, MD, discusses with Joon Park, MD, the national implementation patterns and perioperative outcomes of minimally invasive gastrectomy in gastric cancer surgery in the US. Dr. Park is author of “Disparities in Utilization and Outcomes of Minimally Invasive Techniques for Gastric Cancer Surgery in the United States.” Dr. Joon Park is a Resident of Surgery in the Department of Surgery, UCLA David Geffen School of Medicine, Los Angeles, CA.
Surgical Approach Does Not Affect Return to Intended Oncologic Therapy Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: A Propensity-Matched Study
November 22, 2022 06:00 - 14 minutes - 19.8 MBDr. Rick Greene and Dr. Fadi Dahdaleh discuss the effect of operative approach on overall readiness to commence adjuvant therapy in patients with pancreatic ductal adenocarcinoma undergoing pancreaticoduodenectomy, hypothesizing that minimally invasive pancreaticoduodenectomy improves rates and time to return to intended oncologic therapy compared with open pancreaticoduodenectomy. Dr. Dahdaleh is author of “Surgical Approach does not Affect Return to Intended Oncologic Therapy Following Pan...
Downstaging of Pancreatic Adenocarcinoma with Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival
October 11, 2022 05:00 - 17 minutes - 24 MBRick Greene, MD, discusses with Anne O’Shea, MD, and Timothy Vreeland, MD, the role of neoadjuvant chemotherapy or chemoradiation in the treatment of localized pancreatic adenocarcinoma, and the effect of downstaging on overall survival. Dr. O’Shea and Dr. Vreeland are authors of “Downstaging of Pancreatic Adenocarcinoma with Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival.” Dr. Anne O’Shea is Resident of Surgery in the Department of Surgery at Brooke Army Medical Ce...
The Landmark Series: Appendiceal Primary Peritoneal Surface Malignancy
August 16, 2022 05:00 - 18 minutes - 11.9 MBRick Greene, MD, Alexandra Gangi, MD, and Rupen Shah, MD, discuss the landmark articles on which management of primary appendiceal peritoneal surface malignancies are based. Drs. Gangi and Shah are authors of, “The Landmark Series: Appendiceal Primary Peritoneal Surface Malignancy." Dr. Gangi is Director or the Gastrointestinal Tumor and Cancer Regional Therapies Programs, and Associate Program Director, Complex General Surgical Oncology Program, Division of Surgical Oncology, Cedars Sinai...
Is Medicaid Expansion Narrowing Gaps in Surgical Disparities for Low-Income Breast Cancer Patients?”
July 13, 2022 05:00 - 9 minutes - 12.9 MBRick Greene, MD, and Samilia Obeng-Gyasi, MD, MPH, discuss the effect of Medicaid expansion under the Affordable Care Act on patterns of surgical care among low-income breast cancer patients. Dr. Obeng-Gyasi is author of “Is Medicaid Expansion Narrowing Gaps in Surgical Disparities for Low-Income Breast Cancer Patients?” Dr. Obeng-Gyasi is Assistant Professor of Surgery in the Division of Surgical Oncology at The Ohio State University, Columbus, OH.
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
June 14, 2022 05:00 - 11 minutes - 16.1 MBRick Greene, MD, and Mark Truty, MD, discuss the role of neoadjuvant chemotherapy in the treatment of pancreatic cancer, including the optimal treatment of patients who do not respond to first-line chemotherapy or develop toxicities. Dr. Truty is author of, “Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer.” Dr. Truty is Associate Professor of Surgery, Mayo Clinic, Rochester, MN, where his clinical practice is in the Division of Subspecialty General...
COVID-19 Is Affecting the Presentation and Treatment of Melanoma Patients in the Northeastern United States
May 10, 2022 05:00 - 13 minutes - 17.9 MBRick Greene, MD, and Adam Berger, MD, discuss a shift away from nonurgent and preventative medical care due to the pandemic, related changes in presentation of melanoma patients in surgical clinics, and the likely impact on melanoma diagnoses and prognoses. Dr. Berger is author of, “COVID-19 Is Affecting the Presentation and Treatment of Melanoma Patients in the Northeastern United States.” Dr. Berger is Chief of Melanoma for the multidisciplinary Melanoma and Soft Tissue Surgical Oncology...
Cost Effectiveness of Watch and Wait Versus Resection in Rectal Cancer Patients with Complete Clinical Response to Neoadjuvant Chemoradiation
April 19, 2022 05:00 - 10 minutes - 14.8 MBRick Greene, MD, and Nicole Lopez, MD, discuss a watch and wait approach to treating rectal cancer with complete clinical response after neoadjuvant therapy, which reduces overall costs and increases effectiveness compared with radical resection. Dr. Lopez is author of, “Cost Effectiveness of Watch and Wait Versus Resection in Rectal Cancer Patients with Complete Clinical Response to Neoadjuvant Chemoradiation.” Dr. Lopez is Director of the UC San Diego National Accreditation Program for R...
A Comparison of Patient-Reported Outcomes After Breast-Conserving Surgery and Mastectomy with Implant Breast Reconstruction
March 15, 2022 06:00 - 11 minutes - 15.5 MBIn this episode of Speaking of SurgOnc, Rick Greene, MD, and Mary Gemignani, MD, discuss quality of life outcomes associated with surgical management of early-stage breast cancer. Dr. Gemignani is author of the article, “A Comparison of Patient-Reported Outcomes After Breast-Conserving Surgery and Mastectomy with Implant Breast Reconstruction.” Dr. Gemignani is Professor of Surgery, Weill Cornell Medical College, and Attending Surgeon, Director Breast Surgery Fellowship, Memorial Sloan Kette...
Cultural Complications Curriculum: Applicability to Surgical Oncology Programs and Practices
February 08, 2022 06:00 - 12 minutes - 16.6 MBIn this episode of Speaking of SurgOnc, Rick Greene, MD and Lesly A. Dossett, MD, discuss meeting the needs of an increasingly culturally and racially diverse patient population, as well as support and recruitment of a surgical oncology workforce that better represents all minority groups. Dr. Dossett is author of the article, “Cultural Complications Curriculum: Applicability to Surgical Oncology Programs and Practices.” Dr. Dossett is Associate Professor of Surgery, Chief of the Division ...
Introducing the Ongoing Clinical Trials in the Surgical Oncology Series
January 11, 2022 06:00 - 11 minutes - 15.8 MBIn this episode of Speaking of SurgOnc, Rick Greene, MD and Jonathan M. Hernandez, MD, discuss the need for surgical oncologists to keep informed of ongoing research in multiple arenas and the launch of a new editorial series to address current challenges in meeting this need. Dr. Hernandez is author of the editorial, “Introducing the Ongoing Clinical Trials in the Surgical Oncology Series.” Dr. Hernandez is Associate Professor of Surgery with the Uniformed Services University of the Healt...
Landmark Series on Disparities in Surgical Oncology: Melanoma
December 14, 2021 06:00 - 13 minutes - 19 MBIn this episode of Speaking of SurgOnc, Rick Greene, MD and John H. Stewart, MD, discuss the unequal burden of melanoma between Blacks and whites in the United States and the differences in access to melanoma care. Dr. Stewart is author of the article, “Landmark Series on Disparities in Surgical Oncology: Melanoma.” Dr. Stewart is Professor of Surgery, LSU Health New Orleans School of Medicine, and is Center Director of the LSU Health New Orleans/LCMC Health Cancer Center, New Orleans, LA.
Opioid-Sparing Multimodal Analgesia Protocol for Lumpectomy Patients Results in Superior Postoperative Pain Control
November 09, 2021 06:00 - 11 minutes - 15.5 MBIn this episode of Speaking of SurgOnc, Rick Greene, MD and Kristin E. Rojas, MD, discuss the implementation of an opioid-sparing multimodal analgesia protocol for lumpectomy patients for pain management without a routine opioid prescription. Dr. Rojas is author of the article, “Opioid-Sparing Multimodal Analgesia Protocol for Lumpectomy Patients Results in Superior Postoperative Pain Control.” Dr. Rojas is Assistant Professor of Surgery at the Sylvester Comprehensive Cancer Center, Univer...
Impact of the COVID-19 Pandemic on Cancer Clinical Trials
October 12, 2021 05:00 - 12 minutes - 17.3 MBIn this episode of Speaking of SurgOnc®, Rick Greene, MD, and Judy Boughey, MD, discuss the impact of COVID-19 on US clinical research at the local, cooperative group, and national level. Dr. Boughey is the author of the article, “Impact of the COVID-19 Pandemic on Cancer Clinical Trials.” Dr. Judy Boughey is Professor of Surgery in Division of Breast and Melanoma Surgical Oncology, Department of Surgery at Mayo Clinic, Rochester, MN.
Adherence to NCCN Guidelines for Genetic Testing in Breast Cancer Patients: Who Are We Missing?
August 10, 2021 05:00 - 11 minutes - 15.8 MBRick Greene, MD, and Elisa Port, MD, discuss surgeon adherence to NCCN guidelines and patterns of testing in newly diagnosed breast cancer patients. Dr. Port is author of, “Adherence to NCCN Guidelines for Genetic Testing in Breast Cancer Patients: Who Are We Missing?” Dr. Port is Chief of Breast Surgery and Director of the Dubin Breast Center, Mount Sinai Hospital, and Professor of Surgery, Icahn School of Medicine at Mount Sinai, New York, New York.
Completion Thyroidectomy is Less Common Following Updated 2015 American Thyroid Association Guidelines
July 13, 2021 05:00 - 11 minutes - 15.5 MBRick Greene, MD and Nancy Cho, MD discuss the impact of the 2015 American Thyroid Association guideline change on clinical practice in low-risk differentiated thyroid cancer, specifically regarding the rate of completion thyroidectomy. Dr. Cho is author of the article, “Completion Thyroidectomy is Less Common Following Updated 2015 American Thyroid Association Guidelines.” Dr. Cho is Associate Surgeon, Brigham and Women's Hospital and Dana-Farber Cancer Institute, and Assistant Professor o...
Race and Gender Disparities in Access to Parathyroidectomy: A Need to Change Processes for Diagnosis and Referral to Surgeons
June 15, 2021 05:00 - 8 minutes - 11.8 MBRick Greene, MD, and Courtney Balentine, MD, discuss race and gender disparities in the time from initial diagnosis of hyperparathyroidism to treatment with parathyroidectomy. Dr. Balentine is author of, "Race and Gender Disparities in Access to Parathyroidectomy: A Need to Change Processes for Diagnosis and Referral to Surgeons." Dr. Balentine is Assistant Professor of General and Endocrine Surgery, and Co-Director of the UTSW Surgical Center for Outcomes, Implementation and Novel Interve...
Longitudinal Analysis of Quality-of-Life Recovery After Gastrectomy for Cancer
May 21, 2021 05:00 - 17 minutes - 24.2 MBRick Greene, MD and Vivian Strong, MD discuss factors associated with quality-of-life recovery after gastrectomy. Dr. Strong is author of “Longitudinal Analysis of Quality-of-Life Recovery After Gastrectomy for Cancer.” Dr. Strong is the Iris Cantor Endowed Chair and Attending Surgeon, Memorial Sloan Kettering Cancer Center; Professor of Surgery and Associate Dean, Weill Cornell Medical College of Cornell University; and Vice Chair of Surgery for Surgical Innovations and Outcomes, Memorial...
Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma
March 21, 2021 05:00 - 12 minutes - 17.6 MBRick Greene, MD, and Melissa Hogg, MD, discuss the relationship of serum CA19-9 to other markers of response, and the related thresholds correlating to outcomes, following neoadjuvant therapy for pancreatic adenocarcinoma. Dr. Hogg is author of the article, “Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma.” Dr. Hogg is the Director of HPB Surgery and Director of Robotic Training for Grainger Lab at the Northshore Universi...
Surgical Oncologists and the COVID-19 Pandemic: Guiding Cancer Patients Effectively through Turbulence and Change
February 09, 2021 06:00 - 12 minutes - 17.6 MBRick Greene, MD, and Ken Tanabe, MD, discuss the need for surgical oncologists to remain focused on providing optimal care for our cancer patients while managing the demands that the COVID-19 pandemic continues to impose. Dr. Tanabe is author of, "Surgical Oncologists and the COVID-19 Pandemic: Guiding Cancer Patients Effectively through Turbulence and Change." Dr. Tanabe is a Professor of Surgery at Harvard Medical School and Chief, Division of Gastrointestinal and Oncologic Surgery, Mass...
Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade
January 11, 2021 06:00 - 11 minutes - 16.1 MBRick Greene, MD and Charlotte Ariyan, MD, PhD, discuss survival outcomes in patients with metastatic melanoma who were selected for surgery following checkpoint blockade. Dr. Ariyan is author of, “Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade.” Dr. Ariyan is Associate Professor of Surgery, Weill Cornell Medical College, and a Surgeon with clinical expertise in melanoma and soft tissue sarcoma, at Memorial Sloan Kettering Cancer C...
Opioid Consumption Following Breast Surgery Decreases with a Brief Educational Intervention: A Randomized, Controlled Trial
December 08, 2020 06:00 - 7 minutes - 8.79 MBRick Greene, MD and Katie Egan, MD discuss the use of an educational intervention to decrease opioid consumption among breast surgery patients. Dr. Egan is author of the article, “Opioid Consumption Following Breast Surgery Decreases with a Brief Educational Intervention: A Randomized, Controlled Trial.” Dr. Egan is Plastic and Reconstructive Surgery Resident at The University of Kansas Medical Center in Kansas City, KS.
The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cance
November 10, 2020 06:00 - 13 minutes - 15.7 MBRick Green, MD and Dr. Anna Weiss, MD discuss clinical trials that have defined the role of neoadjuvant endocrine therapy in patients with estrogen receptor-positive breast cancer. Dr. Weiss is author of “The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cancer.” Dr. Weiss is Assistant Professor of Surgery at Harvard Medical School, Boston, MA.
The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cancer
November 10, 2020 06:00 - 13 minutes - 15.7 MBRick Green, MD and Dr. Anna Weiss, MD discuss clinical trials that have defined the role of neoadjuvant endocrine therapy in patients with estrogen receptor-positive breast cancer. Dr. Weiss is author of “The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cancer.” Dr. Weiss is Assistant Professor of Surgery at Harvard Medical School, Boston, MA.
The Landmark Series: Neuroendocrine Tumor Liver Metastases
October 13, 2020 05:00 - 11 minutes - 13.7 MBRick Greene, MD, and Alexandra Gangi, MD and James Howe, MD, discuss current data regarding management of neuroendocrine liver metastases and future areas for study. Dr. Gangi and Dr. Howe are authors of “The Landmark Series: Neuroendocrine Tumor Liver Metastases.” Dr. Gangi is Assistant Professor of Surgery in the Department of Surgical Oncology and the Director of the Gastrointestinal Tumor Program at Cedars-Sinai, Los Angeles, CA. Dr. James Howe is Professor of Surgery and Division Head...
Survival Outcomes of Patients with Clinical Stage III Melanoma in the Era of Novel Systemic Therapies
August 11, 2020 05:00 - 7 minutes - 8.99 MBRick Greene, MD and Giorgos Karakousis, MD discuss the impact of immune checkpoint and BRAF/MEK pathway inhibitors on outcomes and melanoma care at a national population level in patients diagnosed with clinical stage III melanoma. Dr. Karakousis is author of, “Survival Outcomes of Patients with Clinical Stage III Melanoma in the Era of Novel Systemic Therapies.” Dr. Karakousis is Associate Professor of Surgery at the Hospital of the University of Pennsylvania, Philadelphia, PA.
Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases
July 14, 2020 05:00 - 7 minutes - 8 MBRick Greene, MD, and Michael D’Angelica, MD discuss the relationship between hepatic parenchymal disease and recurrence after colorectal liver metastases resection, which has not been well defined. Dr. D’Angelica is author of, “Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases.” Dr. D’Angelica holds the Enid A. Haupt Chair in Surgery at Memorial Sloan Kettering Cancer Center and is Professor of Surgery at Weill Medical College...
Complex General Surgical Oncology Fellowship Applicants: Trends over Time and the Impact of Board Certification Eligibility
June 09, 2020 05:00 - 7 minutes - 9.07 MBRick Greene, MD and Elizabeth Grubbs, MD, MS discuss an analysis of the applicant pool of complex general surgical oncology (CGSO) fellowships and how it has changed over the last decade. Dr. Grubbs is author of, “Complex General Surgical Oncology Fellowship Applicants: Trends over Time and the Impact of Board Certification Eligibility.” Dr. Grubbs is Associate Professor, Program Director of Complex General Surgical Oncology Fellowship, Vice Chair of Education, Department of Surgical Onc...
Symptom burden at the end-of-life for neuroendocrine tumors: an analysis of 2,579 prospectively collected patient-reported outcomes
May 12, 2020 05:00 - 7 minutes - 8.55 MBRick Greene, MD and Julie Hallet, MD discuss the moderate-to-severe symptoms observed to steeply increase as death nears for patients with neuroendocrine tumors (NETs), which highlight an opportunity for improved management. Dr. Hallet is author of, “Symptom Burden at the End of Life for Neuroendocrine Tumors: An Analysis of 2579 Prospectively Collected Patient-Reported Outcomes.” Dr. Hallet is Assistant Professor, Surgical Oncology, University of Toronto and Sunnybrook Health Sciences C...
Germline Genetic Testing: What the Breast Surgeon Needs to Know
April 07, 2020 13:13 - 7 minutes - 8.9 MBDr. Greene and Dr. Plichta discuss the potential benefit for women from genetic testing for BRCA1, BRCA2, and other breast cancer genes and the knowledge needed by breast surgeons to facilitate testing and counseling. Dr. Plichta is author of, “Germline Genetic Testing: What the Breast Surgeon Needs to Know.” Dr. Plichta is an Assistant Professor of Surgery, Division of Surgical Oncology, Duke Surgery, Duke University School of Medicine, Durham, NC.
Maintenance of Certification and Continuing Medical Education: Are They Still Required?
March 10, 2020 05:00 - 5 minutes - 4.35 MBRick Greene, MD and Marissa M. Howard-McNatt, MD discuss how the requirements for maintenance of certification (MOC) and CME changed in 2018, and review the options for completing these requisites. Mariss M. Howard-McNatt, MD is author of, “Maintenance of Certification and Continuing Medical Education: Are They Still Required?” Marissa M. Howard-McNatt, MD is an Associate Professor of Surgery Sciences – Oncology, Wake Forest School of Medicine, Winston-Salem, NC. She is the Director of t...
Young Women with Breast Cancer: Fertility Preservation Options and Management of Pregnancy-Associated Breast Cancer
February 11, 2020 15:33 - 10 minutes - 4.61 MBDr. Greene and Dr. Jeruss discuss the potential impact of treatment on the future fertility of young breast cancer patients and review guidelines provided to address reproductive health in conjunction with a breast cancer diagnosis. Dr. Jeruss is author of, “Young Women with Breast Cancer: Fertility Preservation Options and Management of Pregnancy-Associated Breast Cancer.” Dr. Jeruss is an Associate Professor of Surgery at Departments of Surgery, Pathology, and Biomedical Engineering, U...
Intraoperative Fluorescent Angiography Predicts Pharyngocutaneous Fistula After Salvage Laryngectomy
January 21, 2020 21:07 - 7 minutes - 3.37 MBDr. Rick Greene and Dr. Andrew J. Rosko discuss how intraoperative usage of indocyanine green imaging can predict the formation of post-operative fistulas, allowing for more tailored reconstructive options depending on risk of fistula. Dr. Rosko is author of, “Intraoperative Fluorescent Angiography Predicts Pharyngocutaneous Fistula After Salvage Laryngectomy.” Dr. Rosko is a Clinical Assistant Professor, Department of Otolaryngology-Head and Neck Surgery, at the University of Michigan M...
Adjuvant and Neoadjuvant Therapy, Treatment for Advanced Disease, and Genetic Considerations for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disease Site Working Group
December 10, 2019 06:00 - 9 minutes - 10.8 MBDr. Rick Greene and Dr. Paxton Dickson discuss adrenocortical carcinoma and related issues regarding adjuvant and neoadjuvant therapy, treatment of advanced disease, and genetic considerations for patients who have this disease. Dr. Dickson is author of, “Adjuvant and Neoadjuvant Therapy, Treatment for Advanced Disease, and Genetic Considerations for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disease Site Working Group.” Dr. Dickson currently serves as a...